← Leaderboards
Marc J Kaufman
Mc Lean Hospital (Belmont, Ma)
$9,063,661
Attributed
$11,670,660
Total exposure
17
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,170,660 · 18
By mechanism
R01$8,890,166 · 5
S10$1,000,000 · 6
R21$865,107 · 2
K02$468,333 · 1
R41$319,992 · 1
U18$245,993 · 1
Top collaborators
- Jay P Mclaughlin8 shared
- Samikkannu Thangavel3 shared
- Vlad Bogin1 shared
Most similar at Mc Lean Hospital (Belmont, Ma)
Same institution · by research overlap
- Harrison G Pope$6,350,709
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsBrainMagnetic Resonance SpectroscopyLeadBehavioralFunctional DisorderCocainePharmaceutical PreparationsBehaviorFutureDoseSeveritiesBaseChronicReportingAttenuatedIn VivoGlutamatesNeurochemistryDrug Of AbuseDesignCognitivePreventFunctional Magnetic Resonance Imaging
Grant awards (40)
Impacts of morphine and HIV-Tat exposures and dimethylfumarate treatment on brain BDNF and mitochondrial and behavioral dysfunction.$665,637
R01 · FY2025 · DA
Impacts of morphine and HIV-Tat exposures and dimethylfumarate treatment on brain BDNF and mitochondrial and behavioral dysfunction.$668,482
R01 · FY2024 · DA
Impacts of morphine and HIV-Tat exposures and dimethylfumarate treatment on brain BDNF and mitochondrial and behavioral dysfunction.$697,228
R01 · FY2023 · DA
Brain effects of long-term anabolic-androgenic steroid use:Multimodal imaging and cognition studies$479,270
R01 · FY2021 · DA · contact PI
Portable hand-held proprietary xenon inhaler for rapid reduction of opioid withdrawal symptoms$319,992
R41 · FY2021 · DA
Brain effects of long-term anabolic-androgenic steroid use:Multimodal imaging and cognition studies$479,270
R01 · FY2020 · DA · contact PI
Dimethyl fumarate attenuation of opioid withdrawal symptom severity$245,993
U18 · FY2020 · DA · contact PI
Brain effects of long-term anabolic-androgenic steroid use:Multimodal imaging and cognition studies$479,270
R01 · FY2019 · DA · contact PI
HIV Tat protein mediation of neurochemical changes and increased opioid reward$435,480
R01 · FY2019 · DA
Brain effects of long-term anabolic-androgenic steroid use:Multimodal imaging and cognition studies$479,270
R01 · FY2018 · DA · contact PI
HIV Tat protein mediation of neurochemical changes and increased opioid reward$435,480
R01 · FY2018 · DA
Administrative Supplement to R01DA041866-01A1$431,556
R01 · FY2018 · DA · contact PI
Brain effects of long-term anabolic-androgenic steroid use:Multimodal imaging and cognition studies$478,783
R01 · FY2017 · DA · contact PI
HIV Tat protein mediation of neurochemical changes and increased opioid reward$435,480
R01 · FY2017 · DA
HIV Tat protein mediation of neurochemical changes and increased opioid reward$431,124
R01 · FY2016 · DA
Effects of chronic cocaine on cognition and glutamate levels in nonhuman primates$195,525
R21 · FY2016 · DA · contact PI
HIV Tat protein mediation of neurochemical changes and increased opioid reward$447,980
R01 · FY2015 · DA
Effects of chronic cocaine on cognition and glutamate levels in nonhuman primates$237,000
R21 · FY2015 · DA · contact PI
Concurrent PET D2/D3 receptor imaging and fMRI smoking cue reactivity in smokers$185,271
R21 · FY2013 · DA · contact PI
Is xenon neuroprotective in a mouse model of ALS$76,235
R03 · FY2013 · NS · contact PI
Concurrent PET D2/D3 receptor imaging and fMRI smoking cue reactivity in smokers$247,311
R21 · FY2012 · DA · contact PI
Is xenon neuroprotective in a mouse model of ALS$79,000
R03 · FY2012 · NS · contact PI
Magnetic Resonance, EEG, and Behavior After Cocaine$360,077
R01 · FY2008 · DA · contact PI
Chronic drug exposures in monkeys: serial MRI studies$101,624
K02 · FY2008 · DA · contact PI
Chronic drug exposures in monkeys: serial MRI studies$95,648
K02 · FY2007 · DA · contact PI
Chronic drug exposures in monkeys: serial MRI studies$92,862
K02 · FY2006 · DA · contact PI
Cocaine &Steroids: Brain Vascular &Behavioral Effects$368,204
R01 · FY2005 · DA
Chronic drug exposures in monkeys: serial MRI studies$89,518
K02 · FY2005 · DA
Ultra High Field 9.4T Animal Magnetic Resonance Scanner$500,000
S10 · FY2004 · RR
Cocaine &Steroids: Brain Vascular &Behavioral Effects$368,204
R01 · FY2004 · DA
ULTRA HIGH FIELD 9.4T ANIMAL MAGNETIC RESONANCE SCANNER: NEUROSCIENCES$117,375
S10 · FY2004 · RR
ULTRA HIGH FIELD 9.4T ANIMAL MAGNETIC RESONANCE SCANNER:MENTAL ILLNESS, SCHIZOPH$117,375
S10 · FY2004 · RR
ULTRA HIGH FIELD 9.4T ANIMAL MAGNETIC RESONANCE SCANNER: SUBSTANCE ABUSE$117,375
S10 · FY2004 · RR
ULTRA HIGH FIELD 9.4T ANIMAL MAGNETIC RESONANCE SCANNER: PARKINSON'S DISEASE$117,375
S10 · FY2004 · RR
Chronic drug exposures;serial MRI studies$88,681
K02 · FY2004 · DA
ULTRA HIGH FIELD 9.4T ANIMAL MAGNETIC RESONANCE SCANNER: AIDS$30,500
S10 · FY2004 · RR
Cocaine &Steroids: Brain Vascular &Behavioral Effects$368,204
R01 · FY2003 · DA
Cocaine &Steroids: Brain Vascular &Behavioral Effects$381,167
R01 · FY2002 · DA
MR SPECTROSCOPIC IMAGING OF STIMULANT ABUSE$113,340
K01 · FY2001 · DA
MR SPECTROSCOPIC IMAGING OF STIMULANT ABUSE$112,494
K01 · FY2000 · DA